Global Independent Clinical Laboratories (ICL) Market by Type (Diagnostic Testing Services, Clinical Trials Testing), By Application (Enterprises, Medical Organazations) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2021 To 2030. The global independent clinical laboratories market is expected to grow at a CAGR of 5.5% during the forecast period from 2021 to 2030. The growth of this market is driven by the increasing demand for diagnostic testing services and clinical trials testing in various regions across the globe. The major factors driving this market are increasing number of patients with chronic diseases such as cancer and diabetes; growing awareness about preventive healthcare; rising prevalence of lifestyle-related diseases such as obesity and hypertension; increased government funding for research on chronic diseases; technological advancements in medical equipment which has led to improved accuracy in diagnosis and treatment procedures; increase in number of hospitals globally which has led to an increase in demand for diagnostic testing services among other factors. However, high cost associated with these tests may hamper the growth rate during the forecast period.
Some Of The Growth Factors Of This Market:
- The ICL market is driven by the increasing demand for laboratory testing services in emerging economies such as China and India.
- The ICL market is also driven by the need for accurate and timely diagnosis of diseases, which has led to an increase in demand for laboratory testing services.
- Increasing government initiatives to improve healthcare infrastructure will also drive the growth of the ICL market.
- Increasing awareness about health issues among people will also drive the growth of this market.
Industry Growth Insights published a new data on “Independent Clinical Laboratories (ICL) Market”. The research report is titled “Independent Clinical Laboratories (ICL) Market research by Types (Diagnostic Testing Services, Clinical Trials Testing, Others), By Applications (Enterprises, Medical Organazations), By Players/Companies Quest, Labcorp, Biomnis, KingMed, Adicon, DAZD, Kindstar, Daan Gene, BML, SRL, SYNLAB”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Independent Clinical Laboratories (ICL) Market Research Report
By Type
Diagnostic Testing Services, Clinical Trials Testing, Others
By Application
Enterprises, Medical Organazations
By Companies
Quest, Labcorp, Biomnis, KingMed, Adicon, DAZD, Kindstar, Daan Gene, BML, SRL, SYNLAB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Independent Clinical Laboratories (ICL) Market Report Segments:
The global Independent Clinical Laboratories (ICL) market is segmented on the basis of:
Types
Diagnostic Testing Services, Clinical Trials Testing, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Enterprises, Medical Organazations
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Quest
- Labcorp
- Biomnis
- KingMed
- Adicon
- DAZD
- Kindstar
- Daan Gene
- BML
- SRL
- SYNLAB
Highlights of The Independent Clinical Laboratories (ICL) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Testing Services
- Clinical Trials Testing
- Others
- By Application:
- Enterprises
- Medical Organazations
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Independent Clinical Laboratories (ICL) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Independent Clinical Laboratories (ICL) is a national organization that provides laboratory testing and diagnostic services to physicians, hospitals, clinics and other healthcare providers. ICL operates more than 1,000 laboratories across the United States.
Some of the major players in the independent clinical laboratories (icl) market are Quest, Labcorp, Biomnis, KingMed, Adicon, DAZD, Kindstar, Daan Gene, BML, SRL, SYNLAB.
The independent clinical laboratories (icl) market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Independent Clinical Laboratories (ICL) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Independent Clinical Laboratories (ICL) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Independent Clinical Laboratories (ICL) Market - Supply Chain
4.5. Global Independent Clinical Laboratories (ICL) Market Forecast
4.5.1. Independent Clinical Laboratories (ICL) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Independent Clinical Laboratories (ICL) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Independent Clinical Laboratories (ICL) Market Absolute $ Opportunity
5. Global Independent Clinical Laboratories (ICL) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Type
5.3.1. Diagnostic Testing Services
5.3.2. Clinical Trials Testing
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Independent Clinical Laboratories (ICL) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Application
6.3.1. Enterprises
6.3.2. Medical Organazations
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Independent Clinical Laboratories (ICL) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Independent Clinical Laboratories (ICL) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Independent Clinical Laboratories (ICL) Demand Share Forecast, 2019-2026
9. North America Independent Clinical Laboratories (ICL) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Application
9.4.1. Enterprises
9.4.2. Medical Organazations
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Type
9.7.1. Diagnostic Testing Services
9.7.2. Clinical Trials Testing
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Independent Clinical Laboratories (ICL) Demand Share Forecast, 2019-2026
10. Latin America Independent Clinical Laboratories (ICL) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Application
10.4.1. Enterprises
10.4.2. Medical Organazations
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Type
10.7.1. Diagnostic Testing Services
10.7.2. Clinical Trials Testing
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Independent Clinical Laboratories (ICL) Demand Share Forecast, 2019-2026
11. Europe Independent Clinical Laboratories (ICL) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Application
11.4.1. Enterprises
11.4.2. Medical Organazations
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Independent Clinical Laboratories (ICL) Market Size and Volume Forecast byType
11.7.1. Diagnostic Testing Services
11.7.2. Clinical Trials Testing
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Independent Clinical Laboratories (ICL) Demand Share, 2019-2026
12. Asia Pacific Independent Clinical Laboratories (ICL) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Application
12.4.1. Enterprises
12.4.2. Medical Organazations
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Type
12.7.1. Diagnostic Testing Services
12.7.2. Clinical Trials Testing
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Independent Clinical Laboratories (ICL) Demand Share, 2019-2026
13. Middle East & Africa Independent Clinical Laboratories (ICL) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Application
13.4.1. Enterprises
13.4.2. Medical Organazations
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Independent Clinical Laboratories (ICL) Market Size and Volume Forecast by Type
13.7.1. Diagnostic Testing Services
13.7.2. Clinical Trials Testing
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Independent Clinical Laboratories (ICL) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Independent Clinical Laboratories (ICL) Market: Market Share Analysis
14.2. Independent Clinical Laboratories (ICL) Distributors and Customers
14.3. Independent Clinical Laboratories (ICL) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Quest
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Labcorp
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Biomnis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. KingMed
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Adicon
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. DAZD
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Kindstar
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Daan Gene
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BML
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. SRL
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. SYNLAB
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook